Indian Journal of Nuclear Medicine

COMMENTARY
Year
: 2020  |  Volume : 35  |  Issue : 4  |  Page : 281--282

Making the case for prostate-specific membrane antigen-targeted positron emission tomography/computed tomography in suspected prostate cancer


Harmandeep Singh 
 Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India

Correspondence Address:
Dr. Harmandeep Singh
Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh - 160 012
India

Prostate specific membrane antigen (PSMA) over-expression is a hallmark of prostate adenocarcinoma and many PSMA targeting positron emission tomography (PET) radiopharmaceuticals have been developed over the last decade. The role of 68Ga-PSMA-11 PET-computed tomography (CT) is well established in staging and biochemical recurrence of PCa, with growing interest and evidence regarding its utility in suspected prostate cancer.


How to cite this article:
Singh H. Making the case for prostate-specific membrane antigen-targeted positron emission tomography/computed tomography in suspected prostate cancer.Indian J Nucl Med 2020;35:281-282


How to cite this URL:
Singh H. Making the case for prostate-specific membrane antigen-targeted positron emission tomography/computed tomography in suspected prostate cancer. Indian J Nucl Med [serial online] 2020 [cited 2021 Jan 27 ];35:281-282
Available from: https://www.ijnm.in/article.asp?issn=0972-3919;year=2020;volume=35;issue=4;spage=281;epage=282;aulast=Singh;type=0